Fu's Subcutaneous Needling Treatment for Biceps Tendinopathy

计划入组 32 人 · 首次发布于 2020 年 5 月 14 日

Fu's Subcutaneous Needling Treatment for Knee Osteoarthritis

计划入组 32 人 · 首次发布于 2020 年 4 月 22 日

Fu's Subcutaneous Needling Treatment for Hemiplegic Shoulder Pain

计划入组 48 人 · 首次发布于 2021 年 10 月 20 日

Bisphosphonates subcutaneous (Halozyme)

C1 Esterase Inhibitor Subcutaneous (Human)

Immune Globulin Subcutaneous (Human) (Octapharma)

ALTEOGEN Inc.

South Korea

scPharmaceuticals

United States

KORU Medical Systems

United States

Fu's Subcutaneous Needling vs. Electroacupuncture for Knee Osteoarthritis: A Pilot Study

Merck Accelerates Subcutaneous Keytruda Launch Following Positive Phase 3 Results

FDA Approves Subcutaneous Atezolizumab (Tecentriq Hybreza) for Multiple Cancers